Abstract Submission Guidelines

1. Please read the instructions carefully, abstracts must be submitted according to these guidelines, instructions and required information as stated:
   1. All abstracts must be submitted in English.
   2. Category
      Select the category which BEST describes the content of your abstract. Categories are used for reviewing and indexing purposes.
   3. Abstract Title
      The abstract title should not exceed 120 characters excluding spaces and should be brief and relevant. Special characters should NOT be used in your title but spelt out instead (e.g. α should be written as alpha, β as beta). Only use standard abbreviations and generic drug names in the title. Capitalise each word in the title.
   4. Abstract Body
      
      • Structure: The abstract should have the following sub-headings: - Introduction, Methods, Results, and Conclusion.
      • Layout: Please fill in according to the sections provided. Do not include graphs, tables or illustrations in the abstract.
      • Word count: The abstract is limited to 300 words.
      • Only commonly accepted abbreviations should be used (e.g. OGTT, IGT, ACEI). Less widely recognised abbreviations may be used if introduced on first usage (e.g. ambulatory blood pressure monitoring, ABPM).
      • Only approved and generic (non-proprietary) drug names should be used.
      • Do NOT enter the title, authors, or grant information into the abstract body submission field.
   5. Abstracts can only be submitted electronically through official Congress website (www.memsmac.org). Abstract sent by post, fax or email WILL NOT BE ACCEPTED.
   6. Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be printed in the abstract/programme book exactly as submitted.
2. Delegate may submit more than ONE abstract (please use the same email address).
3. Only submission received by 30th April 2020 will be eligible for Best Oral & Best Poster prizes.
4. Accepted abstracts will appear in print as submitted. Please ensure you check your data carefully before submitting.
5. An acknowledgement letter will be sent to you once you have successfully submitted your abstracts. Please contact the Congress Secretariat at secretariat@memsmac.org if you do not receive the acknowledgement letter.
6. All submitted abstracts will undergo a peer-review process by a panel of expert reviewers. Accepted abstracts will be selected for either oral or poster presentation. The MAC Scientific Committee reserves the right to re-categorise any accepted abstract. The decision of the committee is final and irrevocable.
7. All accepted abstracts will be printed in the Journal of the ASEAN Federation of Endocrine Societies (JAFES), or in a Supplementary copy.
8. Abstract submitters will be informed of the status of their abstracts once the reviewing process is completed.
9. Once an abstract is selected for presentation, at least one of the authors MUST register for the congress. Payment for the congress registration should reach the Congress Secretariat before 22nd June 2020 to ensure that your abstracts will be published in the journal.
10. The MAC Scientific Committee reserves the rights to disqualify the abstract if any needs are not met.
11. Authors will be notified of the method of presentation, which will be decided by the MAC Scientific Committee.
12. Judges’ decisions are final, and no appeal will be entertained.